通过改进的单细胞新rna测序技术（NASC-seq2），研究深入揭示了转录爆发的动力学原理，发现了合成率在决定转录爆发规模中的关键作用。 本研究的 ...

UK biotech MiNA Therapeutics’ RNA-based gene-activating technology has caught the eye of big pharma AstraZeneca. AZ has teamed up with the London-based startup to develop its small, activating ...

UK biotech MiNA Therapeutics has signed up another big pharma partner for its small activating RNA (saRNA) platform, which upregulates the activity of proteins, with Eli Lilly the latest to get in ...